Malindang, Lyne Z.

HRN: 17-20-02  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/24/2023
CEFTRIAXONE 1G (VIAL)
10/24/2023
10/31/2023
IV
2g
OD ( ) ANST
T/C Acute AP
Waiting Final Action 
10/27/2023
CEFUROXIME 1.5GM (VIAL)
10/27/2023
10/27/2023
IV
1.5grams
On Call To OR
For STAT Pelvic Lap
Waiting Final Action 
10/27/2023
CEFUROXIME 1.5GM (VIAL)
10/27/2023
10/30/2023
IV
1.5gm
Q8 3 Days
S/P PELVIC LAP
Waiting Final Action 
10/29/2023
CEFUROXIME 500MG (TAB)
10/29/2023
11/05/2023
PO
500mg
BID
S/P Pelvic Lapaorotomy
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: